This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08274/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08274/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08274/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08274/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08274
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB08274 n12:DB08274
dcterms:title
6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE
adms:identifier
n9:DB08274 n10:99444745 n11:NIU n13:5289034
n4:IUPAC-Name
n5:271B482E-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B4834-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B4833-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B4830-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B4831-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B4832-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B482C-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B482D-363D-11E5-9242-09173F13E4C5 n5:271B482A-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B482B-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B483A-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B483B-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4835-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4836-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4838-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4837-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4839-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B4840-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B4842-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B4843-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B483F-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B483E-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B4841-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B482F-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B483C-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B483D-363D-11E5-9242-09173F13E4C5